Analytical Data
-
Gene name
HEMGN
- Application
-
Alternative Names
HEMGN；EDAG；NDR；Hemogen
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BXL5
-
Expression Region
1-484aa
-
AA Sequence
MDLGKDQSHL KHHQTPDPHQ EENHSPEVIG TWSLRNRELL RKRKAEVHEK ETSQWLFGEQ KKRKQQRTGK GNRRGRKRQQ NTELKVEPQP QIEKEIVEKA LAPIEKKTEP PGSITKVFPS VASPQKVVPE EHFSEICQES NIYQENFSEY QEIAVQNHSS ETCQHVSEPE DLSPKMYQEI SVLQDNSSKI CQDMKEPEDN SPNTCQVISV IQDHPFKMYQ DMAKREDLAP KMCQEAAVPK ILPCPTSEDT ADLAGCSLQA YPKPDVPKGY ILDTDQNPAE PEEYNETDQG IAETEGLFPK IQEIAEPKDL STKTHQESAE PKYLPHKTCN EIIVPKAPSH KTIQETPHSE DYSIEINQET PGSEKYSPET YQEIPGLEEY SPEIYQETSQ LEEYSPEIYQ ETPGPEDLST ETYKNKDVPK ECFPEPHQET GGPQGQDPKA HQEDAKDAYT FPQEMKEKPK EEPGIPAILN ESHPENDVYS YVLF
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HEMGN (Heme Oxygenase-1 Mimic Gene Network) recombinant proteins have garnered significant interest in biomedical research due to their potential applications in various therapeutic contexts. HEMGN is involved in the regulation of heme metabolism and possesses various biological functions, including anti-inflammatory and antioxidant activities. Studies have shown that the modulation of heme metabolism can have profound effects on cellular physiology and disease states, particularly in conditions such as neurodegeneration, cardiovascular diseases, and cancer. Researchers have been focusing on the characterization and functional analysis of HEMGN recombinant proteins to better understand their role in cellular pathways and to explore their potential as therapeutic agents. By utilizing recombinant DNA technology, scientists can produce these proteins in a controlled and efficient manner, enabling detailed studies of their biochemical properties and interactions. The development of HEMGN-based therapies holds promise for enhancing cellular resilience and promoting recovery in damaged tissues. Furthermore, the exploration of HEMGN's mechanisms of action may reveal novel targets for drug development, paving the way for innovative treatments for a variety of ailments. As the field progresses, the continuous investigation into the properties and applications of recombinant HEMGN proteins may lead to breakthroughs in personalized medicine and improved therapeutic strategies.
